Literature DB >> 12592402

Toll-like receptor-4 (TLR4) signaling augments chemokine-induced neutrophil migration by modulating cell surface expression of chemokine receptors.

Jie Fan1, Asrar B Malik.   

Abstract

Polymorphonuclear leukocytes (PMNs) are critical effector cells of the innate immune system that protect the host by migrating to inflammatory sites and killing pathogenic microbes. We addressed the role of chemokine receptor desensitization induced by G-protein-coupled receptor kinases (GRKs) in the feedback control of PMN migration. We show that the chemokine macrophage inflammatory protein-2 (MIP-2) induces GRK2 and GRK5 expression in PMNs through phosphoinositide-3-kinase (PI3K)-gamma signaling. We also show that lipopolysaccharide (LPS)-activated signaling through the Toll-like receptor (TLR)-4 pathway transcriptionally downregulates the expression of GRK2 and GRK5 in response to MIP-2. The reduced expression of GRKs lowers chemokine receptor desensitization and markedly augments the PMN migratory response. These data indicate that TLR4 modulation of PMN surface chemokine receptor expression subsequent to the downregulation of GRK2 and GRK5 expression is a critical determinant of PMN migration.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12592402     DOI: 10.1038/nm832

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  97 in total

Review 1.  The potential for Toll-like receptors to collaborate with other innate immune receptors.

Authors:  Subhankar Mukhopadhyay; Jurgen Herre; Gordon D Brown; Siamon Gordon
Journal:  Immunology       Date:  2004-08       Impact factor: 7.397

2.  Interaction of Bartonella henselae with endothelial cells promotes monocyte/macrophage chemoattractant protein 1 gene expression and protein production and triggers monocyte migration.

Authors:  Amy M McCord; Andrew W O Burgess; Melissa J Whaley; Burt E Anderson
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

Review 3.  Reactive oxygen species in inflammation and tissue injury.

Authors:  Manish Mittal; Mohammad Rizwan Siddiqui; Khiem Tran; Sekhar P Reddy; Asrar B Malik
Journal:  Antioxid Redox Signal       Date:  2013-10-22       Impact factor: 8.401

4.  Clinical observation on effect of triptolide tablet in treating patients with psoriasis vulgaris.

Authors:  Shao-xi Wu; Ning-ru Guo
Journal:  Chin J Integr Med       Date:  2005-06       Impact factor: 1.978

Review 5.  From the Th1/Th2 paradigm towards a Toll-like receptor/T-helper bias.

Authors:  Mihai G Netea; Jos W M Van der Meer; Roger P Sutmuller; Gosse J Adema; Bart-Jan Kullberg
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

6.  Susceptibility genes for age-related maculopathy on chromosome 10q26.

Authors:  Johanna Jakobsdottir; Yvette P Conley; Daniel E Weeks; Tammy S Mah; Robert E Ferrell; Michael B Gorin
Journal:  Am J Hum Genet       Date:  2005-07-26       Impact factor: 11.025

7.  Regulation of chemokine receptor by Toll-like receptor 2 is critical to neutrophil migration and resistance to polymicrobial sepsis.

Authors:  Jose C Alves-Filho; Andressa Freitas; Fabricio O Souto; Fernando Spiller; Heitor Paula-Neto; Joao S Silva; Ricardo T Gazzinelli; Mauro M Teixeira; Sergio H Ferreira; Fernando Q Cunha
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-20       Impact factor: 11.205

Review 8.  Cell penetrating peptide inhibitors of nuclear factor-kappa B.

Authors:  J S Orange; M J May
Journal:  Cell Mol Life Sci       Date:  2008-11       Impact factor: 9.261

Review 9.  Linking oxidative stress to inflammation: Toll-like receptors.

Authors:  Roop Gill; Allan Tsung; Timothy Billiar
Journal:  Free Radic Biol Med       Date:  2010-01-18       Impact factor: 7.376

10.  Toll-like receptor 4 is essential to preserving cardiac function and survival in low-grade polymicrobial sepsis.

Authors:  Ming Zhang; Lin Zou; Yan Feng; Yu-Jung Chen; Qichang Zhou; Fumito Ichinose; Wei Chao
Journal:  Anesthesiology       Date:  2014-12       Impact factor: 7.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.